Back to search

United Kingdom· GB-APID-22122011000001102

Remifentanil 1mg powder for concentrate for solution for injection vials

A remifentanil product containing remifentanil, registered in United Kingdom by Actavis UK Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC N01AH06

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRemifentanil 1mg powder for concentra…ATCN01AH06REGISTER NO.GB-APID-2212201100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Remifentanil is registered in 18 of 19 countries.

Countries holding a registration under ATC N01AH06 (remifentanil), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Remifentanil · ATC N01AH06

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of remifentanil costs, country by country.

Normalised to the WHO defined daily dose (52.5 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Remifentanil · price per daily dose (52.5 mcg)

USD · FX 28 Sept 2026

  • FI Finland$0.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Remifentanil
Manufacturer
Actavis UK Ltd
Country
United Kingdom (GB)
ATC code
N01AH06
ATC class
Remifentanil
Defined daily dose
52.5 mcg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5012617021991

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

123 interactions on record for remifentanil.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Remifentanil · interactions on record

123 records

  • 18 severe
  • 91 moderate
  • 14 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Remifentanil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All remifentanil products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Remifentanil Hameln, Remifentanil Kabi
  • Belgium · Ultiva
  • Bulgaria · Ремифентанил Хамелн, Ремифентанил-Чайкафарма
  • Cyprus · Refenta
  • Czechia · Remifentanil B. Braun
  • Germany · Remifentanil B. Braun, Remifentanil Genmed
  • Denmark · Remifentanil B. Braun, Remifentanil Fresenius Kabi
  • Estonia · Remifentanil Kabi
  • Spain · Remifentanilo Kern Pharma, Remifentanilo Noridem
  • Finland · Remifentanil, Remifentanil B. Braun
  • France · Remifentanil Piramal, Remifentanil Viatris
  • Greece · Dormiden, Remifentanil Anfarm
  • Croatia · Remifentanil Hameln
  • Ireland · Remifentanil, Remifentanil Fresenius Kabi Deutschland
  • Iceland · Remifentanil Hameln
  • Italy · Remifentanil Hameln, Remifentanil Mylan Generics
  • Lithuania · Remifentanil Kabi
  • Luxembourg · Ultiva
  • Latvia · Remifentanil Kabi
  • Malta · Remifentanil Anfarm, Remifentanil Noridem
  • Netherlands · Remifentanil B. Braun, Remifentanil Fresenius Kabi
  • Norway · Remifentanil Hameln, Remifentanil Orion
  • Poland · Ultiva
  • Portugal · Remifentanilo Accord, Remifentanilo Asklepius
  • Romania · Remifentanil Kabi
  • Sweden · Remifentanil B. Braun, Remifentanil Hameln
  • Slovenia · Remifentanil Hameln
  • Slovakia · Remifentanil B. Braun, Ultiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f685ba22-35f7-4f9e-a7fa-2ef9b675cb95
GET /v1/drugs/f685ba22-35f7-4f9e-a7fa-2ef9b675cb95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "22122011000001102",
  "desc": "Remifentanil 1mg powder for concentrate for solution for injection vials (Actavis UK Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "42017011000001100",
  "source": "dmd",
  "vtm_id": "777417003",
  "strength": "1 mg",
  "substance": "Remifentanil",
  "ingredient": "Remifentanyl hydrochloride",
  "supplier_code": "3875201000001104"
}

See everything about remifentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.